Agopton 30
Agopton 30 is an originator product from Takeda Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 26.65 to CHF 52.35 depending on the pack; the patient co-payment is 40 per cent plus the deductible.
Core data
- Authorisation holder
- Takeda Pharma AG
- ATC code
- A02BC03
- IT group
- 04.99 Varia
- Active substances
- Lansoprazolum
- Preparation type
- Originator product
- On the SL since
- 15/03/1994
- Last price change
- 01/07/2026
- Co-payment
- 40%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Kaps 30 mg | 14 Stk | CHF 9.46 | CHF 26.65 | 15/03/1994 | B | 7680519690140 |
| Kaps 30 mg | 28 Stk | CHF 18.10 | CHF 35.90 | 15/03/1994 | B | 7680519690225 |
| Kaps 30 mg | 56 Stk | CHF 33.46 | CHF 52.35 | 15/04/2000 | B | 7680519690300 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Agopton 30 covered by Swiss health insurance?
Yes. Agopton 30 is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 40 per cent.
What does Agopton 30 cost in Switzerland?
The public price is the maximum price set by the FOPH and for Agopton 30 ranges from CHF 26.65 to CHF 52.35 per pack. The ex-factory price ranges from CHF 9.46 to CHF 33.46. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages